The PRIMA Menopause Test detects Follicle Stimulating Hormone (FSH) in urine. Elevated FSH levels are often associated with perimenopause or menopause, since the ovaries begin to produce less estrogen and the body increases FSH to try to stimulate them.

How It Works:

• The test uses lateral flow immunoassay technology, similar to a pregnancy test.

• It detects FSH concentrations equal to or greater than 25 mIU/mL.

• A positive result may suggest that a woman is entering menopause.

• Ideally, the test is done twice, spaced 5–7 days apart, to improve reliability.

• 🔍 Results Interpretation:

  • Positive: Two lines (test + control) = FSH ≥ 25 mIU/mL → possible menopausal transition

  • Negative: Only control line = FSH below threshold → likely not menopausal

  • Invalid: No control line → test error

📦 What’s in the Box:

• 2 test devices (to be used on separate days)

• Instructions for use

⚠️ Important Notes & Limitations:

• Not a diagnostic tool: This is a screening aid, not a substitute for a medical diagnosis.

• FSH can fluctuate, especially during perimenopause, so clinical correlation is essential.

• Certain medications (e.g., hormone therapy or fertility meds) can affect accuracy.

• Does not detect estrogen levels or confirm postmenopausal status with certainty.

• Women on birth control or with hormonal imbalances (e.g. PCOS) should consult a healthcare provider before relying on results.

This test is helpful for women experiencing menopausal symptoms who want an early indication of hormonal changes. However, because hormone levels fluctuate, a positive result should be followed up with your GP or pharmacist. For the most reliable results, test twice, 5–7 days apart, using the first urine of the day.